Drug Information

Drug General Information
Drug ID
D00VHN
Former ID
DNC005084
Drug Name
3-(N-alkylamino) propylphosphonic acid derivative
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527193]
Structure
Download
2D MOL

3D MOL
Formula
C19H35NO5P+
Canonical SMILES
CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO[P+](O)(O)O)N
InChI
1S/C19H35NO5P/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-25-26(22,23)24/h9-12,21-24H,2-8,13-16,20H2,1H3/q+1
InChIKey
CGCGFGUOJDITDE-UHFFFAOYSA-N
PubChem Compound ID
46905530
Target and Pathway
Target(s) Sphingosine 1-phosphate receptor 1 Target Info Inhibitor [527193]
KEGG Pathway FoxO signaling pathway
Sphingolipid signaling pathway
Neuroactive ligand-receptor interaction
NetPath Pathway IL4 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
IL2 Signaling Pathway
Pathway Interaction Database Fc-epsilon receptor I signaling in mast cells
S1P3 pathway
S1P1 pathway
Sphingosine 1-phosphate (S1P) pathway
PDGFR-beta signaling pathway
Reactome G alpha (i) signalling events
Lysosphingolipid and LPA receptors
WikiPathways Signal Transduction of S1P Receptor
Small Ligand GPCRs
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 527193Bioorg Med Chem Lett. 2004 Oct 4;14(19):4861-6.Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) receptors.
Ref 527193Bioorg Med Chem Lett. 2004 Oct 4;14(19):4861-6.Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) receptors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.